AME Company for Medical Supplies

SAU:9527Healthcare

SAR 70.40+0.00%At closeAt close · Mon 19 Oct · ≈ AED 68.95 · Market cap $131.41M

SAR millions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Revenue	121.6	151.4	193.2	223.3	248.4	305.0	+22.8%
Cost of revenue	66.6	81.8	102.9	124.6	148.0	176.5	+19.2%
Gross profit	55.0	69.5	90.3	98.8	100.3	128.5	+28.1%
Research & development	0.0	0.0	0.0	0.0	0.0	0.0	—
Selling, general & administrative	32.4	28.3	36.4	37.2	55.2	37.7	−31.7%
Selling & marketing	23.0	23.8	29.9	34.3	41.3	26.5	−35.9%
Operating expenses	32.4	45.0	60.3	61.5	51.0	85.6	+67.7%
Operating income	22.6	24.5	30.0	37.3	49.3	42.1	−14.7%
Interest expense	0.0	0.2	0.3	0.7	0.2	2.3	+1226.7%
Interest income	0.0	0.0	0.0	0.0	0.0	0.6	—
Other income / expense	(0.0)	(0.3)	0.1	0.3	0.3	(3.3)	−1419.7%
Pre-tax income	22.6	24.2	30.0	37.6	50.0	38.7	−22.6%
Income tax	1.5	3.0	3.3	4.1	4.6	3.7	−19.9%
Net income	21.1	21.2	26.7	33.5	45.4	35.0	−22.9%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—
Other net income adjustments	0.0	0.0	0.0	0.0	0.0	0.0	—
EPS, basic (per share)	3.01	3.05	3.81	4.79	6.49	5.00	−23.0%
EPS, diluted (per share)	3.01	3.05	3.81	4.79	6.49	5.00	−23.0%
EBITDA	22.9	24.8	31.0	39.3	52.0	43.7	−16.1%
Depreciation & amortization	0.3	0.5	0.9	1.5	1.8	1.6	−12.7%
Weighted average shares (shares)	7,000,000	6,955,038	7,000,000	7,000,000	7,000,000	7,002,000	+0.0%
Weighted average diluted shares (shares)	7,000,000	6,955,038	7,000,000	7,000,000	7,000,000	7,002,000	+0.0%
Gross margin	45.2%	45.9%	46.7%	44.2%	40.4%	42.1%	+1.7 pts
Operating margin	18.6%	16.2%	15.5%	16.7%	19.9%	13.8%	−6.1 pts
Net margin	17.3%	14.0%	13.8%	15.0%	18.3%	11.5%	−6.8 pts

SAR millionsUpdated 31 Dec 2025 ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.